Back to Search Start Over

Scientific Opinion on Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3): consideration of genotoxicity data on alicyclic aldehydes with α,β‐unsaturation in ring/side‐chain and precursors from chemical subgroup 2.2 of FGE.19

Authors :
EFSA Panel on Food Additives and Flavourings (FAF)
Maged Younes
Gabriele Aquilina
Laurence Castle
Karl‐Heinz Engel
Paul Fowler
Maria Jose Frutos Fernandez
Peter Fürst
Rainer Gürtler
Ursula Gundert‐Remy
Trine Husøy
Peter Moldeus
Agneta Oskarsson
Romina Shah
Ine Waalkens‐Berendsen
Detlef Wölfle
Romualdo Benigni
Claudia Bolognesi
Kevin Chipman
Eugenia Cordelli
Gisela Degen
Daniel Marzin
Camilla Svendsen
Maria Carfì
Natalia Kovalkovicova
Carla Martino
Giorgia Vianello
Wim Mennes
Source :
EFSA Journal, Vol 17, Iss 1, Pp n/a-n/a (2019)
Publication Year :
2019
Publisher :
Wiley, 2019.

Abstract

Abstract The EFSA Panel on Food Additives and Flavourings was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3). In FGE.208Rev1, the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) evaluated genotoxicity studies on the representative substance p‐mentha‐1,8‐dien‐7‐al [FL‐no: 05.117], which was found to be genotoxic in vivo. The Panel concluded that there was a potential safety concern for the nine substances in this FGE that were all represented by [FL‐no: 05.177]. Consequently, substance [FL‐no: 05.117], as well as four substances ([FL‐no: 05.121, 09.272, 09.899 and 09.900]), no longer supported by industry were deleted from the Union List. In FGE.208Rev2, the Panel assessed genotoxicity studies submitted on five flavouring substances [FL‐no: 02.060, 02.091, 05.106, 09.278 and 09.302] and concluded that the concern for genotoxicity could be ruled out for these substances, except from myrtenal [FL‐no: 05.106] for which the available data were considered equivocal. Thus, industry provided additional genotoxicity studies (a bacterial reverse mutation assay and a combined in vivo bone marrow erythrocytes micronucleus test and Comet assay in liver and duodenum) for this substance which were evaluated in the present opinion, FGE.208Rev3. Based on these new data, the Panel concluded that the concern for genotoxicity could be ruled out for myrtenal [FL‐no: 05.106]. Subsequently, this substance can be evaluated through the Procedure.

Details

Language :
English
ISSN :
18314732
Volume :
17
Issue :
1
Database :
Directory of Open Access Journals
Journal :
EFSA Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.46efd754f240739a8d062d0350b7d4
Document Type :
article
Full Text :
https://doi.org/10.2903/j.efsa.2019.5569